Skip to main content

Month: June 2023

Interactive Strength Inc. Secures $15M Credit Facility to Support Increased Demand

AUSTIN, TX, June 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Interactive Strength Inc. d/b/a FORME (the “Company”, or “FORME”) (NASDAQ: TRNR), maker of premium smart home gyms and provider of virtual personal training services, announces that on June 6th the Company signed a note purchase agreement to issue senior secured notes (the “Notes”) with gross proceeds to the Company of up to $15.0 million. The lead investor has committed to purchase at least $7.5 million of the Notes and the Notes have a two-year maturity, at 10.0% interest per annum, and with a 5.0% original issuance discount, representing a total cost of debt of 12.5% over the term of the Notes. FORME recently announced partnerships with the luxury hotel chain Aethos and sports retail company SIGNA Sports United. Aethos has hotels and...

Continue reading

HashiCorp 2023 State of Cloud Strategy Survey Shows Cloud Maturity Drives Operational Efficiency

Survey highlights the benefits of reaching cloud maturity, including retaining talent, cost savings, security posture, and operational efficiency SAN FRANCISCO, June 12, 2023 (GLOBE NEWSWIRE) — HashiCorp, Inc. (NASDAQ: HCP), a leading provider of multi-cloud infrastructure automation software, today released its 2023 State of Cloud Strategy Survey, showing positive business outcomes for organizations that demonstrate high maturity in adopting, standardizing, and scaling their multi-cloud adoption. This year’s survey, commissioned by HashiCorp and once again performed by Forrester Consulting, focuses on operational cloud maturity, defined by the adoption of a combination of technological and organizational best practices at scale. Results highlighted that high-maturity organizations benefit most in the areas of security, governance,...

Continue reading

21Shares Launches World’s First ETP Offering Single Asset Exposure to Lido DAO

The 21Shares Lido DAO ETP will provide investors with access to Lido DAO ecosystem ZURICH, June 12, 2023 – 21Shares AG (“21Shares”), the world’s largest issuer of cryptocurrency exchange traded products (ETPs) and a subsidiary of 21.co, today announced the launch of the 21Shares Lido DAO ETP (LIDO). This product offers investors first-of-its-kind single asset exposure to Lido DAO (“Lido”), the market-leading liquid staking solution for various Proof-of-Stake (PoS) blockchains, including Ethereum, Polygon and Solana. Lido’s mission is to make staking simple, secure and decentralized. It does so by enabling users to stake their assets and receive an equal amount of staked tokens (“stTokens”) in return, which accrue staking rewards. These stTokens can then also be traded on the secondary market and used within DeFi applications,...

Continue reading

Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

The Company expands technology for patients with obsessive-compulsive disorder MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that they have received 510(k) clearance for their obsessive-compulsive disorder (OCD) Motor Threshold (MT) Cap technology for NeuroStar® Advanced Therapy for Mental Health. “This FDA clearance underscores our commitment to delivering the latest technology that will streamline the treatment process for our customers,” shared Cory Anderson, SVP of R&D and Clinical at Neuronetics. “The unique design and functionality of the OCD MT Cap will enable clinicians to optimize treatment efficiency...

Continue reading

Lleida.net obtains a new Indian patent for its method for certifying the sending of electronic email, and exceeds 300

MADRID, Spain, June 12, 2023 (GLOBE NEWSWIRE) — Spanish listed company Lleida.net (OTCQX:LLEIF) (EPA:ALLLN) (BME:LLN), a leader in the registered electronic signature, notification and contracting industry, has reached a significant milestone with the granting of its 301st patent in India, this time for its innovative method of certifying the sending of emails. The patent, numbered 434112 and granted by Intellectual Property India, reinforces the company’s commitment to continue developing disruptive technologies to address the challenges of the digital world in the world’s most populous market. India has 1,428 million inhabitants and a penetration of more than 1.25 billion cell phones, of which more than 850 million are smartphones. Valid until 2033, and under the title “METHOD FOR CERTIFYING THE SENDING OF ELECTRONIC...

Continue reading

Cumulus Media Announces Preliminary Results of Tender Offer

ATLANTA, June 12, 2023 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company” or “Cumulus”) today announced the preliminary results of its “modified Dutch auction” tender offer, which expired at midnight, New York City time, at the end of the day on June 9, 2023. Based on the preliminary count by Continental Stock Transfer & Trust Company, the depositary for the tender offer, a total of 1,745,005 shares of the Company’s Class A common stock were validly tendered at or below a purchase price $3.25 per share and not validly withdrawn, including 5,000 shares of the Company’s Class A common stock that were tendered through notice of guaranteed delivery. In accordance with the terms and conditions of the tender offer and based on the preliminary count by the depositary, the Company expects...

Continue reading

AIM ImmunoTech Outlines Recent Significant Progress Across Clinical Development Pipeline and Provides Update on Positive Pre-Clinical and IP Developments

Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site now open at University of Nebraska for Phase 2 study of Ampligen® for the treatment of pancreatic cancer (AMP-270) Ongoing progress toward Phase 1 data in clinical development program of Ampligen for the treatment of early-stage triple negative breast cancer Significant findings from a new analysis support the potential to identify patients with LAPC that could respond better to Ampligen Company bolsters patent portfolio for Ampligen as a potential therapy against Ebola virus disease OCALA, Fla., June 12, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers,...

Continue reading

OMNIQ’s CEO DISCUSSES THE POWER OF MACHINE VISION AND THE OPPORTUNITY AHEAD ON THE PLANET MICRO CAP PODCAST

SALT LAKE CITY / UTAH , June 12, 2023 (GLOBE NEWSWIRE) — omniQ Corp. (NASDAQ: OMQS), an object identification company providing Artificial Intelligence (AI)-based technology solutions CEO Shai Lustgarten sits down with Robert Kraft, CEO of Planet Microcap to discuss the power of Machine Vision and the opportunity ahead. Links below: YouTube: https://www.youtube.com/watch?v=kmb7JSkA7Xo Apple: https://podcasts.apple.com/us/podcast/omniq-corp-nasdaq-omqs-creates-automation-through-object/id1024217659?i=1000616242494 Spotify: https://open.spotify.com/episode/2mtW1Ke2kZOQKGLya5S6RI Podbean: https://planetmicrocap.podbean.com/e/omniq-corp-nasdaq-omqs-creates-automation-through-object-identification/ Substack: https://microcapnewsletter.substack.com/p/omniq-corp-nasdaq-omqs-creates-automation#details About omniQ: OMNIQ Corp. provides...

Continue reading

Northview Fund announces recapitalization transaction including the acquisition of three portfolios for $742 million and its intention to transform into Northview Residential REIT, a $2.7 billion, internally managed, traditional open-ended real estate investment trust focused on national multi-family properties

HighlightsNorthview will acquire over 3,300 multi-family suites and 119,000 commercial square feet for $742 million in exchange for Northview Fund units, exchangeable units and redeemable units at an issue price of $15.06 per unit and the assumption of in-place financing Northview Residential REIT’s portfolio will consist of 14,622 multi-family suites and execusuites and 1.25 million square feet of commercial space, located across nine provinces and two territories, providing investors with a diversified portfolio of significant scale with access to new growth opportunities Northview Residential REIT will increase its support from its existing institutional investors, including affiliates of Starlight Investments and KingSett Capital, as well as a new, significant investment from a global institutional investor Upon closing of the...

Continue reading

B2Gold Provides Details For Attending and Voting at the Upcoming 2023 Annual General & Special Meeting; Leading Independent Proxy Advisory Firm, ISS, Recommends Shareholders Vote For All Proposed Items

VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) will host its 2022 Annual General and Special Meeting of Shareholders (the “Meeting”) on Friday, June 23, 2023, at 2:00 pm PT / 5:00 pm ET. B2Gold is pleased to announce the support of Institutional Shareholder Services (“ISS”), who has recommended that shareholders vote FOR all proposed items to be considered at the upcoming Meeting. The Meeting will be held at the Fairmont Hotel Vancouver, Pacific Ballroom, 900 West Georgia Street, Vancouver, BC, Canada, V6C 2W6, and in a virtual format conducted via live audio webcast online. The Meeting will be available to registered and non-registered shareholders and guests, and accessible via live webcast by clicking here: https://web.lumiagm.com/485739236. B2Gold...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.